CYMBALTA showed improvement over placebo on the primary endpoint [change from baseline to end-of-treatment on the Brief Pain Inventory (BPI) Modified Short Form: Adolescent Version 24-hour average pain severity rating] with a p-value of 0.052 from the pre-specified primary analysis, and p-values ranging from 0.011-0.020 from sensitivity analyses which assigned baseline values to missing assessments of some patients who did not complete the trial for various reasons
Ulcerative colitis can sometimes impair the bodys ability to absorb nutrients, and if Ozempic slows digestion too much, it could complicate this further
This ancient Ayurvedic remedy contains over 80 minerals and powerful compounds like fulvic acid that may support various aspects of female wellness
Reconstituted storage summary Temperature danger zones: what happens when storage goes wrong Understanding exactly what happens at different temperatures helps you make informed decisions when storage conditions are not perfect
Patel claims that he has developed a stable form of NAD+, but given its constraints with oral consumption, he is conducting extensive research on optimizing delivery, focusing on topical, sublingual, and nasal delivery
